C07C69/003

ANTIFOAM AND DEFOAMER PRODUCT
20230047489 · 2023-02-16 ·

The present invention relates to a combination of specific alcohol and ester and their use as antifoam and/or defoamer. It also concerns compositions comprising it, and methods for reducing foam formation and for breaking a foam.

ANTIFOAM AND DEFOAMER PRODUCT
20230047489 · 2023-02-16 ·

The present invention relates to a combination of specific alcohol and ester and their use as antifoam and/or defoamer. It also concerns compositions comprising it, and methods for reducing foam formation and for breaking a foam.

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)

A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):

##STR00001##

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)

A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):

##STR00001##

ALKOXYCARBONYLATION OF TRIVINYLCYCLOHEXANE

Process for the alkoxycarbonylation of trivinylcyclohexane.

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES
20230210800 · 2023-07-06 ·

The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitis, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

Vegetable oil-based alkoxylates and methods of making such

A vegetable oil-based alkoxylate composition comprising a mixture of mono-, di-, and/or triacyl alkoxylated glycerides and alkoxylated glycerin. A method of reacting a vegetable oil and an alkoxylated glycerin via a transesterification reaction to produce a vegetable oil-based alkoxylate composition.

TCD-Esters for Low Temperature Liquid Applications

The present invention relates to the use of esters of octahydro-4,7-methano-1H-indene-5-methanol (TCD-M) or -dimethanol (TCD-DM) and aliphatic C2-C18 monocarboxylic acids as lubricants in low temperature applications. In addition, the present invention relates to low-temperature lubricant compositions comprising said esters.

Alkoxycarbonylation of trivinylcyclohexane

Process for the alkoxycarbonylation of trivinylcyclohexane.

Electrolytic solution, electrochemical device, lithium ion secondary battery, and module

An electrolyte solution containing a compound represented by the following formula (1): ##STR00001##
wherein R.sup.101 and R.sup.102 are the same as or different from each other and are each a hydrogen atom, a fluorine atom, or an alkyl group optionally containing a fluorine atom; and R.sup.103 is an alkyl group or an organic group containing an unsaturated carbon-carbon bond. Also disclosed is an electrochemical device and lithium ion secondary battery including the electrolyte solution, and a module including the electrochemical device or lithium ion secondary battery.